Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
about
Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis.Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?Ribavirin in the treatment of chronic hepatitis C.Treatment of chronic hepatitis C in hemodialysis patients.Anemia management in patients with chronic viral hepatitis C.The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis CApplicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.Viral hepatitis after liver transplantation.Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.Anemia is not predictive of sustained virological response in liver transplant recipients with hepatitis C virus who are treated with pegylated interferon and ribavirin.Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years.
P2860
Q35808230-4B72DA7B-E562-4CD7-BE77-B2F6390A355FQ36028318-DDBCD9E3-B652-42D4-BF51-963447236B73Q36775650-13715062-4441-4C8F-8603-63883812F0C0Q37075834-40167D5B-E847-40B5-B968-913ADFA31D86Q37195248-84389CAF-F50B-4ABA-AE89-D327E880F092Q37313163-57E31E89-C736-4740-8928-B69FE7A4B8A3Q38079528-B5A80DFA-C7B5-47DA-878D-613349F6B475Q38915259-F4CD3E5A-BF8F-4179-BCB5-A15EC3D61132Q40456443-3371579C-23EE-4581-8DCE-2531E449B059Q43453679-13C55471-190B-426C-B581-19EC8B7758C3Q44880244-B5E0E71B-ABB9-45F1-90DF-69D2D9FDE6D7Q45364962-F07BC450-A33B-46AB-941E-7E60F0ADF8E6Q46646250-9898700E-3DBC-4416-AE9F-267C8C004D5F
P2860
Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Ribavirin dose modification ba ...... h hepatitis C virus infection.
@en
Ribavirin dose modification ba ...... h hepatitis C virus infection.
@nl
type
label
Ribavirin dose modification ba ...... h hepatitis C virus infection.
@en
Ribavirin dose modification ba ...... h hepatitis C virus infection.
@nl
prefLabel
Ribavirin dose modification ba ...... h hepatitis C virus infection.
@en
Ribavirin dose modification ba ...... h hepatitis C virus infection.
@nl
P2093
P2860
P356
P1476
Ribavirin dose modification ba ...... h hepatitis C virus infection.
@en
P2093
A Obaid Shakil
Ashok B Jain
Igor Dvorchik
Leah Kingery
Paulo A Fontes
Raman Venkataramanan
Randeep Kashyap
P2860
P304
P356
10.1053/JLTS.2002.36241
P577
2002-11-01T00:00:00Z